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Abstract
Background: Inappropriate prescription of antibiotics may contribute towards higher levels antimicrobial resistance. A key
intervention for improving appropriate antibiotic prescription is surveillance of prescription. This paper presents the results
of a longitudinal surveillance of broad-spectrum antibiotic prescription in 5 public-sector hospitals in Singapore from 2006
to 2010.
Methodology/Principal Findings: Quarterly antibiotic prescription data were obtained and converted to defined daily
doses (DDDs) per 1,000 inpatient-days. The presence of significant trends in antibiotic prescription over time for both
individual and combined hospitals was tested by regression analysis and corrected for autocorrelation between time-points.
Excluding fluoroquinolones, there was a significant increase in prescription of all monitored antibiotics from an average of
233.12 defined daily doses (DDD)/1,000 inpatient-days in 2006 to 254.38 DDD/1,000 inpatient-days in 2010
(Coefficient=1.13, 95%CI: 0.16–2.09, p=0.025). Increasing utilization of carbapenems, piperacillin/tazobactam, and Gram-
positive agents were seen in the majority of the hospitals, while cephalosporins were less prescribed over time. The
combined expenditure for 5 hospitals increased from USD9.9 million in 2006 to USD16.7 million in 2010.
Conclusions/Significance: The rate of prescription of broad-spectrum antibiotics in Singaporean hospitals is much higher
compared to those of European hospitals. This may be due to high rates of antimicrobial resistance. The increase in
expenditure on monitored antibiotics over the past 5 years outstripped the actual increase in DDD/1,000 inpatient-days of
antibiotics prescribed. Longitudinal surveillance of antibiotic prescription on a hospital and countrywide level is important
for detecting trends for formulating interventions or policies. Further research is needed to understand the causes for the
various prescription trends and to act on these where necessary.
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Introduction
Antibiotics are an invaluable shared resource that is at risk of
becoming both scarce and less effective in the face of a diminishing
antibiotic pipeline and rising antimicrobial resistance [1]. A key
component for improving appropriate antibiotic prescription is
surveillance of prescription, and this may also indirectly contribute
towards reducing antimicrobial resistance via establishment of
national or institutional benchmarks, and heightening awareness
[2,3]. Information obtained from longitudinal surveys may also help
identify trends in antibiotic prescribing and thus guide policy.
Combined with similar surveillance of antimicrobial resistance,
correlations between specific antibiotic prescription and resistance
trendsmay be made that can help pinpoint intervention targets[4–6].
High antimicrobial resistance rates are prevalent in Singapor-
ean hospitals [6,7], resulting in widespread prescription of broad-
spectrum antibiotics that in turn may select out even more
antimicrobial-resistant pathogens [6]. Moreover, the proportion of
inappropriately prescribed antibiotics is not low, with up to 40% of
carbapenem prescriptions found to be inappropriate in a recent
point-prevalence study involving three major local hospitals [8].
The Network for Antimicrobial Resistance Surveillance (Singa-
pore) was established in 2006 to conduct laboratory- and
pharmacy-based surveillance of antimicrobial resistance and
antibiotic prescription in local public sector hospitals. The aim
was to collate reliable data at institutional and national level, and
analyze their trends over time, ultimately developing a tool that
would allow for comparison with a national benchmark. This
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28751paper presents the results of the longitudinal surveillance of broad-
spectrum antibiotic prescription from 2006 to 2010. A portion of
the results from 2006 to 2008 had previously been analyzed in
conjunction with Gram-negative resistance data, where relatively
few correlations were found between prescription and resistance
[6].
Results
Broad-spectrum antibiotic prescription results according to
antibiotic class are depicted in Figure 1, with significant trends
in prescription over time by class and individual antibiotic
highlighted in Table 1. There was a significant increase in
prescription of all surveyed antibiotics excluding fluoroquinolones
from an average of 233.12 defined daily doses (DDD)/1,000
inpatient-days in 2006 to 254.38 DDD/1,000 inpatient-days in
2010 (Coefficient=1.13, 95%CI: 0.16–2.09, p=0.025), although
the correlation coefficient (R
2) was low at 0.28. Inclusion of the
fluoroquinolones – which as a class comprised more than 60% of
all antibiotics monitored – rendered the results non-significant.
The increase in prescription of carbapenems, piperacillin/
tazobactam, polymyxins and Gram-positive agents was balanced
by a decrease in cephalosporin prescription and non-significant
trend towards reduction of prescription of fluoroquinolones.
The trends in prescription of individual antibiotics within major
antibiotic classes are depicted in Figure 2. In line with what was
previously described, imipenem prescription continued to decrease
while meropenem and ertapenem prescription increased. Cipro-
floxacin remained by far the most common antibiotic prescribed
among those monitored, although prescription trends were stable
from 2006 to 2010. Linezolid prescription increased significantly
from 2006, but remained a fraction of vancomycin prescription.
Newly introduced antibiotics such as tigecycline, daptomycin and
doripenem were rarely prescribed.
Table 2 shows the trends in prescription among individual
hospitals. In general, these mirrored the combined results, with
increased prescription of carbapenems, piperacillin/tazobactam,
and Gram-positive agents in at least 3 hospitals, while cephalo-
sporins were less prescribed over time. Hospital 5, the smallest
hospital, saw no significant change in prescription trends for any
antibiotic.
Trends in actual expenditure on antibiotics monitored per 100
inpatient-days are shown in Table 3 and Figure 3. The combined
expenditure for 5 hospitals increased from USD9.9 million in 2006
to USD16.7 million in 2010, with a similar scale of increase seen in
Hospitals 2-4.
Discussion
This work adds to the available sparse literature on country-
level reports of hospital antibiotic consumption [9–11]. The
surveillance program provides participating hospitals useful data
Figure 1. Prescription trends for major antibiotic classes and broad-spectrum antibiotics in Singaporean hospitals, 2006-2010.
doi:10.1371/journal.pone.0028751.g001
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for benchmarking at the individual hospital level. The results of
our surveillance call attention to the extensive prescription of
broad-spectrum antibiotics in Singaporean hospitals. This is much
higher compared to results from European hospitals [9–11], but is
similar to those from a neighboring Asian hospital [12]. Part of this
may be attributable to the high rates of antimicrobial resistance in
the region [6,7,12,13] that in turn drive up prescription of Gram-
positive agents, carbapenems and polymyxins respectively.
However, local rates of methicillin-resistant Staphylococcus
aureus (approximately 40% of all S. aureus), extended-spectrum
beta-lactamase (ESBL)-producing Enterobacteriaceae (approxi-
mately 20% and 35% of all Escherichia coli and Klebsiella
pneumoniae respectively) and carbapenem-resistant Pseudomonas
aeruginosa (approximately 9% of all P. aeruginosa)h a v en o t
increased over the five-year period. It is plausible that with
greater awareness of these pathogens, clinicians were progres-
sively prescribing more broad-spectrum antibiotics despite the
lack of change in resistance trends. The issue of inappropriate
prescription had been examined recently – the results with
regards to carbapenem usage are consistent with findings in
hospitals elsewhere [8].
Table 1. Significant trends in antibiotic prescription in all Singaporean hospitals, 2006 to 2010.
Antibiotic Trend Coefficient 95% confidence interval p-value R
2
All carbapenems Increasing 0.931 0.608–1.255 ,0.001 0.684
Ertapenem Increasing 0.461 0.279–0.644 ,0.001 0.625
Imipenem Decreasing 20.357 20.572 – 20.141 0.003 0.418
Meropenem Increasing 0.810 0.565–1.056 ,0.001 0.741
All cephalosporins Decreasing 21.752 22.204 – 21.300 ,0.001 0.797
Ceftriaxone Decreasing 20.946 21.412 – 20.480 ,0.001 0.503
Ceftazidime Decreasing 20.370 20.463 – 20.277 ,0.001 0.806
Piperacillin/tazobactam Increasing 1.43 0.919 – 1.946 ,0.001 0.671
Gram-positive agents Increasing 0.412 0.263 – 0.561 ,0.001 0.666
Vancomycin Increasing 0.191 0.043 – 0.340 0.015 0.302
Linezolid Increasing 0.132 0.080 – 0.183 ,0.001 0.631
Polymyxins Increasing 0.099 0.062 – 0.135 ,0.001 0.658
doi:10.1371/journal.pone.0028751.t001
Figure 2. Prescription trends for individual antibiotics within major classes of broad-spectrum antibiotics in Singaporean hospitals,
2006–2010. (A) Fluoroquinolones. (B) Third and fourth generation cephalosporins. (C) Carbapenems. (D) Gram-positive agents.
doi:10.1371/journal.pone.0028751.g002
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Third- and 4
th-generation cephalosporin prescription decreased
even as piperacillin/tazobactam prescription increased in three
hospitals. In Hospital 3, this hadb e e na c t i v e l ye n c o u r a g e di na n
effort to decrease the rates of ESBL-producing Enterobacteri-
aceae by decreasing cephalosporin selection pressure. The
cause(s) for the switch in the other hospitals is less clear,
although more aggressive marketing by the pharmaceutical
industry and/or the direct impact of antimicrobial stewardship
programs (ASPs) that had been established in Hospitals 1-3
between 2008 and 2009 cannot be ruled out as contributing
causes. Ertapenem and meropenem prescription had increased
at the cost of imipenem prescription – dosing advantages in the
former and the perceived advantage of reduced neurological
adverse effects in the latter had impelled the shift in prescription
trends. In Hospitals 1 and 3, ertapenem had been promoted
over the other carbapenems because of its lack of selective
pressure on carbapenem-resistant non-fermenting Gram-nega-
tive bacteria [14].
The increase in expenditure on monitored antibiotics over the
past 5 years reflects the actual increase in DDD/1,000 inpatient-
days of antibiotics prescribed. The primary reason is that there was
an increase in prescription of more expensive antibiotics (such as
carbapenems, linezolid and piperacillin-tazobactam) whereas
prescription of some of the cheaper generic antibiotics (ciproflox-
acin, ceftriaxone and ceftazidime) had decreased. Among the three
hospitals with ASPs, broad-spectrum antibiotic expenditure failed
to increase only in Hospital 1, but this was the only institution
where the ASP had covered all inpatient wards by 2010 [15].
Hospital 5 saw reduced patient numbers and antibiotic prescrip-
tion in the first half of 2010 as it wound down its operations.
There are a number of limitations of this work. Firstly, we did
not correlate antibiotic usage with resistance. However, this had
been attempted previously with few significant results [6], and
there is always a concern that multiple cross-correlations between
antibiotic prescription and resistance will result in findings that
arise purely by chance. Secondly, we only monitored prescription
at a hospital-wide level and were therefore unable to drill down to
Table 2. Trends in antibiotic prescription in individual Singaporean hospitals, 2006 to 2010.
Antibiotic Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5
All carbapenems - Increasing Increasing Increasing -
Ertapenem Increasing Increasing Increasing - -
Imipenem Decreasing - - - -
Meropenem Increasing Increasing - Increasing -
All cephalosporins - Decreasing Decreasing - -
Ceftriaxone - - Decreasing - -
Ceftazidime Decreasing Decreasing Decreasing - -
Cefepime - - - - N.A.*
Piperacillin/tazobactam Increasing Increasing Increasing - -
Gram-positive agents - - Increasing Increasing -
Vancomycin - - Increasing Increasing -
Linezolid - - - Increasing -
All fluoroquinolones Decreasing - - Increasing -
Ciprofloxacin Decreasing - - Increasing -
Levofloxacin - Increasing - N.A.* -
Moxifloxacin - N.A.* N.A.* - N.A.*
Amikacin - Decreasing - - -
Aztreonam - - - Increasing -
Polymyxins Increasing - Increasing Increasing -
*N.A. = not available
doi:10.1371/journal.pone.0028751.t002
Table 3. Trends in expenditure on surveyed antibiotics in Singaporean hospitals, 2006 to 2010.
Hospital Trend Coefficient 95% confidence interval p-value R
2
Hospital 1 Stable 12.61 23.52 – 28.73 0.117 0.138
Hospital 2 Increasing 35.14 12.51 – 57.77 0.005 0.422
Hospital 3 Increasing 22.78 14.57 – 30.98 ,0.001 0.669
Hospital 4 Increasing 30.15 10.44 – 49.95 0.005 0.380
Hospital 5 Stable 4.22 215.41 – 23.86 0.656 0.012
Combined Hospitals Increasing 19.81 9.24 – 30.37 0.001 0.479
doi:10.1371/journal.pone.0028751.t003
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prescribing the bulk of these antibiotics. Thirdly, we had
monitored antibiotic prescription trends purely in terms of
DDD, and comparison with other forms of measurement such
as prescribed daily doses have yielded discrepant results [16].
Nonetheless, for such macroscopic trending, DDD as unit of
measurement is likely to be sufficient. Fourthly, narrow-spectrum
antibiotics were not surveyed, and these results could have
provided insight into the possible substitution of broad- for
narrow-spectrum antibiotics. Beyond this, however, the additional
utility of such data is unclear. Lastly, the nature of database
surveillance is such that further work is required to determine and
understand the causes for these trends, as by themselves, the
paucity of data precludes further analysis.
In conclusion, longitudinal surveillance of antibiotic prescription
on a hospital and countrywide level is important for detecting trends
for the ultimate basis of formulating interventions or policies.
Further research is needed to understand the causes for the various
prescription trends and to act on these where necessary. It is
important to note that both surveillance without intervention and
intervention without surveillance are inefficient practices.
Materials and Methods
This was a longitudinal multicenter database surveillance study
carried out over a period of 5 years from 2006 to 2010. Five of 6
public sector hospitals in Singapore participated in the study – the
sixth was a maternal and child hospital that was excluded because
the large pediatric population would affect measurements of
antibiotic prescription. There were 2 tertiary hospitals (Hospitals 1
and 2) and 3 secondary hospitals (Hospitals 3-5) ranging between
400 to 1,600 beds in size.
Antibiotic prescription data were extracted from each hospital’s
electronic pharmacy records. These figures comprise actual prescrip-
tion data rather than purchase data. The antibiotics tracked included
the carbapenems (imipenem, meropenem, doripenem and ertape-
nem), 3
rd and 4
th generation cephalosporins (ceftriaxone, ceftazidime
and cefepime), fluoroquinolones (ciprofloxacin, levofloxacin and
moxifloxacin), b-lactam/b-lactamase inhibitors (piperacillin/tazobac-
tam), Gram-positive agents (vancomycin, linezolid and daptomycin)
and others (amikacin, tigecycline and polymyxins). Denominator data
in the form of hospital inpatient-days, i.e. the sum of each daily
inpatient census every quarter, were obtained from each hospital’s
administrative records. The defined daily dose (DDD) per 1,000
inpatient-days for each drug and drug category prescribed every
quarter was calculated following the World Health Organization
(WHO) anatomical therapeutic chemical (ATC) classification of 2011
[17]. Drug expenditure was calculated based on cost price (in United
States dollar at the current exchange rate) adjusted per 100 inpatient-
days. The total broad-spectrum antibiotic expenditure for combined
hospitals was also tabulated.
Figure 3. Trend in expenditure on broad-spectrum antibiotics in Singaporean hospitals, 2006–2010.
doi:10.1371/journal.pone.0028751.g003
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Corporation, College Station, TX, USA). The presence of
significant trends in antibiotic prescription over time for both
individual and combined hospitals was tested by regression
analysis and corrected for autocorrelation between time-points
by using the Cochrane-Orcutt estimation following determination
of the Durbin-Watson statistic. A trend was considered significant
if the regression analysis showed a p-value of # 0.05 and
coefficient of determination (R
2) greater than 0.3. Because
tigecycline, daptomycin and doripenem were launched in
Singapore within this period (2006, 2008, 2010 respectively) and
prescription volumes were low, these antibiotics were not analyzed
individually.
Acknowledgments
The other members of the Network for Antimicrobial Resistance
Surveillance (Singapore) include Dr Tse Hsien Koh, Dr Andrea Kwa
and Dr Nancy Tee.
We would like to thank A/Prof Dale Fisher, Dr David Lye, Ms Liew
Hong Yin and Ms Serene Yeow for their assistance in data collection.
Author Contributions
Conceived and designed the experiments: L-YH PK T-YT. Performed the
experiments: Y-XL C-LY S-YL W-PL WL. Analyzed the data: L-YH WL
Y-XL. Contributed reagents/materials/analysis tools: L-YH. Wrote the
paper: Y-XL L-YH. Provided the overall framework and necessary liaisons
for the experiments: NARSS.
References
1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, et al. (2009) Bad
bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of
America. Clin Infect Dis 48: 1–12.
2. World Health Organization (2001) WHO global strategy for containment of
antimicrobial resistance. Available at: http://whqlibdoc.who.int/hq/2001/
WHO_CDS_CSR_DRS_2001.2.pdf [Accessed 2nd May 2011].
3. Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr., et al. (2002)
Monitoring antimicrobial use and resistance: comparison with a national
benchmark on reducing vancomycin use and vancomycin-resistant enterococci.
Emerg Infect Dis 8: 702–7.
4. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group
(2005) Outpatient antibiotic use in Europe and association with resistance: a
cross-national database study. Lancet 9459: 579–87.
5. Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ, the Finnish
Study Group for Antimicrobial Resistance (2009) Association between
antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents
Chemother 53: 913–7.
6. Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, et al. (2010) Surveillance and
correlation of antibiotic prescription and resistance of Gram-negative bacteria in
Singaporean hospitals. Antimicrob Agents Chemother. 54: 1173–8.
7. Hsu LY, Tan TY, Jureen R, Koh TH, Krishnan P, et al. (2007) Antimicrobial
drug resistance in Singapore hospitals. Emerg Infect Dis 13: 1944–7.
8. Liew YX, Lee W, Kwa AL, Lye DC, Yeo CL, et al. (2011) Inappropriate
carbapenem use in Singapore public hospitals: opportunities for antimicrobial
stewardship. Int J Antimicrob Agents 37: 87–8.
9. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H; European
Survaillance of Antibiotic Comsuption (ESAC) Project Group (2006) Hospital
consumption of antibiotics in 15 European countries: results of the ESAC
Retrospective Data Collection (1997-2002). J Antimicrob Chemother 58:
159–67.
10. Dumartin C, L’Heriteau F, Pefau M, Bertrand X, Jarno P, et al. (2010)
Antibiotic use in 530 French hospitals: results from a surveillance network at
hospital and ward levels in 2007. J Antimicrob Chemother 65: 2028–36.
11. Ansari F, Molana H, Goossens H, Davey P; ESAC II Hospital Care Study
Group (2010) Development of standardized methods for analysis of changes in
antibacterial use in hospitals from 18 European countries: the European
Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-
06. J Antimicrob Chemother 65: 2685–91.
12. Lai CC, Wang CY, Chu CC, Tan CK, Lu CL, et al. (2011) Correlation between
antibiotic consumption and resistance of Gram-negative bacteria causing
healthcare-associated infections at a university hospital in Taiwan from 2000
to 2009. J Antimicrob Chemother. In press.
13. Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, et al. (2005)
Regional variation in the prevalence of extended-spectrum beta-lactamase-
producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
Diagn Microbiol Infect Dis 52: 323–9.
14. Eagye KJ, Nicolau DP (2011) Change in antipseudomonal carbapenem
susceptibility in 25 hospitals across 9 years is not associated with the use of
ertapenem. J Antimicrob Chemother. In press.
15. Teo J, Kwa AL, Loh J, Chlebicki MP, Lee W (2011) The effect of a whole-
system approach in an antimicrobial stewardship programme at the Singapore
General Hospital. Eur J Clin Microbiol Infect Dis. In press.
16. Muller A, Monnet DL, Talon D, Henon T, Bertrand X (2006) Discrepancies
between prescribed daily doses and WHO defined daily doses of antibacterials at
a university hospital. Br J Clin Pharmacol 61: 585–91.
17. World Health Organization (2011) WHO Collaborating Centre for Drug
Statistics Methodology. ATC/DDD index 2011. Available: http://www.whocc.
no/atc_ddd_index/Accessed 5 May 2011.
Antibiotic Prescription Surveillance, Singapore
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28751